$OTRK
Ontrak, Inc.

2016 Q2 Form 10-Q Financial Statement

#000143774916037506 Filed on August 15, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2015 Q2
Revenue $1.223M $472.0K
YoY Change 159.11% 51.28%
Cost Of Revenue $1.162M $529.0K
YoY Change 119.66% 98.13%
Gross Profit $61.00K -$57.00K
YoY Change -207.02% -226.67%
Gross Profit Margin 4.99% -12.08%
Selling, General & Admin $2.140M $2.420M
YoY Change -11.57% 41.52%
% of Gross Profit 3508.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $30.00K $30.00K
YoY Change 0.0% 50.0%
% of Gross Profit 49.18%
Operating Expenses $3.330M $2.981M
YoY Change 11.71% 48.75%
Operating Profit -$2.107M -$2.509M
YoY Change -16.02% 48.29%
Interest Expense $591.0K $1.110M
YoY Change -46.76% -24.08%
% of Operating Profit
Other Income/Expense, Net -$510.0K $10.00K
YoY Change -5200.0% -99.16%
Pretax Income -$4.717M -$585.0K
YoY Change 706.32% -97.87%
Income Tax $3.000K $2.000K
% Of Pretax Income
Net Earnings -$4.720M -$587.0K
YoY Change 704.09% -97.86%
Net Earnings / Revenue -385.94% -124.36%
Basic Earnings Per Share -$0.51
Diluted Earnings Per Share -$0.51 -$100.0K
COMMON SHARES
Basic Shares Outstanding 9.168M 35.38K
Diluted Shares Outstanding 9.168M 35.38M

Balance Sheet

Concept 2016 Q2 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $100.0K $200.0K
YoY Change -50.0% -81.82%
Cash & Equivalents $52.00K $152.0K
Short-Term Investments
Other Short-Term Assets $300.0K $600.0K
YoY Change -50.0% 500.0%
Inventory
Prepaid Expenses
Receivables $900.0K $200.0K
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.291M $987.0K
YoY Change 30.8% -29.5%
LONG-TERM ASSETS
Property, Plant & Equipment $407.0K $314.0K
YoY Change 29.62% -21.5%
Goodwill
YoY Change
Intangibles $92.00K
YoY Change
Long-Term Investments
YoY Change
Other Assets $371.0K $521.0K
YoY Change -28.79% 30.25%
Total Long-Term Assets $778.0K $927.0K
YoY Change -16.07% 3.0%
TOTAL ASSETS
Total Short-Term Assets $1.291M $987.0K
Total Long-Term Assets $778.0K $927.0K
Total Assets $2.069M $1.914M
YoY Change 8.1% -16.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $734.0K $610.0K
YoY Change 20.33% 103.33%
Accrued Expenses $2.500M $2.200M
YoY Change 13.64% 15.79%
Deferred Revenue
YoY Change
Short-Term Debt $6.100M $2.336M
YoY Change 161.13%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $17.32M $5.967M
YoY Change 190.31% 98.9%
LONG-TERM LIABILITIES
Long-Term Debt $100.0K $0.00
YoY Change
Other Long-Term Liabilities $2.100M $1.200M
YoY Change 75.0% -97.16%
Total Long-Term Liabilities $2.200M $1.200M
YoY Change 83.33% -97.16%
TOTAL LIABILITIES
Total Short-Term Liabilities $17.32M $5.967M
Total Long-Term Liabilities $2.200M $1.200M
Total Liabilities $19.46M $7.178M
YoY Change 171.05% -84.12%
SHAREHOLDERS EQUITY
Retained Earnings -$270.8M -$255.3M
YoY Change 6.05%
Common Stock $6.000K $5.000K
YoY Change 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$17.39M -$5.264M
YoY Change
Total Liabilities & Shareholders Equity $2.069M $1.914M
YoY Change 8.1% -16.78%

Cashflow Statement

Concept 2016 Q2 2015 Q2
OPERATING ACTIVITIES
Net Income -$4.720M -$587.0K
YoY Change 704.09% -97.86%
Depreciation, Depletion And Amortization $30.00K $30.00K
YoY Change 0.0% 50.0%
Cash From Operating Activities -$1.430M -$1.790M
YoY Change -20.11% 31.62%
INVESTING ACTIVITIES
Capital Expenditures -$20.00K -$10.00K
YoY Change 100.0% 0.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities -$20.00K -$10.00K
YoY Change 100.0% -75.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.240M 1.860M
YoY Change -33.33% 2.76%
NET CHANGE
Cash From Operating Activities -1.430M -1.790M
Cash From Investing Activities -20.00K -10.00K
Cash From Financing Activities 1.240M 1.860M
Net Change In Cash -210.0K 60.00K
YoY Change -450.0% -85.37%
FREE CASH FLOW
Cash From Operating Activities -$1.430M -$1.790M
Capital Expenditures -$20.00K -$10.00K
Free Cash Flow -$1.410M -$1.780M
YoY Change -20.79% 31.85%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
cats Fair Value Adjustment Of Derivatives
FairValueAdjustmentOfDerivatives
2844000
cats Fair Value Adjustment Of Derivatives
FairValueAdjustmentOfDerivatives
CY2016Q2 cats Gain Loss On Exchange Of Warrants
GainLossOnExchangeOfWarrants
CY2015Q2 cats Gain Loss On Exchange Of Warrants
GainLossOnExchangeOfWarrants
-4410000
cats Gain Loss On Exchange Of Warrants
GainLossOnExchangeOfWarrants
cats Gain Loss On Exchange Of Warrants
GainLossOnExchangeOfWarrants
-4410000
CY2016Q2 cats Working Capital Deficit
WorkingCapitalDeficit
16000000
CY2016Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
734000
CY2015Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
753000
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1543000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1491000
CY2016Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
253402000
CY2015Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
253053000
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
660000
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1056000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4866927
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2635635
CY2016Q2 us-gaap Assets
Assets
2069000
CY2015Q4 us-gaap Assets
Assets
2880000
CY2016Q2 us-gaap Assets Current
AssetsCurrent
1291000
CY2015Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
66000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
52000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
916000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
708000
CY2015Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
152000
CY2016Q2 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
106000
CY2015Q4 us-gaap Assets Current
AssetsCurrent
2081000
CY2016Q2 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
106000
CY2016Q2 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
56000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-864000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-556000
CY2016Q2 us-gaap Cash Uninsured Amount
CashUninsuredAmount
0
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55007761
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55007761
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55007761
CY2015Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55007761
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
6000
CY2015Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2016Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
CY2015Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
3662000
CY2016Q2 us-gaap Cost Of Services
CostOfServices
1162000
CY2015Q2 us-gaap Cost Of Services
CostOfServices
529000
us-gaap Cost Of Services
CostOfServices
2128000
us-gaap Cost Of Services
CostOfServices
935000
CY2016Q2 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0
CY2015Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
0
CY2016Q2 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0
CY2015Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
0
CY2015Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
2348000
CY2016Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
64000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
63000
CY2016Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
5192000
CY2015Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
CY2016Q2 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
158000
CY2015Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
198000
CY2016Q2 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
2801000
CY2015Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1683000
CY2016Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
32000
CY2015Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
30000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
64000
CY2016Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
6105000
CY2015Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1905000
CY2015Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1703000
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
667000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y127D
CY2016Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
522000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
750000
CY2015Q2 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-7434000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-9908000
CY2016Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-1500000
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
-2800000
CY2015Q2 us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
0
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Gain Loss Included In Earnings
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationGainLossIncludedInEarnings
0
CY2016Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-1507000
CY2015Q2 us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
-2844000
us-gaap Gain Loss On Derivative Instruments Net Pretax
GainLossOnDerivativeInstrumentsNetPretax
CY2016Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2136000
CY2015Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2422000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4323000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5156000
CY2016Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
1223000
CY2015Q2 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
472000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
1951000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
905000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4717000
CY2015Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-585000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-9007000
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-843000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000
CY2015Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4564000
us-gaap Operating Income Loss
OperatingIncomeLoss
-5250000
CY2016Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
586000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
4000
us-gaap Income Taxes Paid
IncomeTaxesPaid
37000
us-gaap Income Taxes Paid
IncomeTaxesPaid
34000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
397000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
478000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
339000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-230000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1118000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
499000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-45000
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-34000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-245000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-118000
CY2016Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
10000
CY2015Q2 us-gaap Interest And Other Income
InterestAndOtherIncome
10000
us-gaap Interest And Other Income
InterestAndOtherIncome
75000
us-gaap Interest And Other Income
InterestAndOtherIncome
21000
CY2016Q2 us-gaap Interest Expense
InterestExpense
591000
CY2015Q2 us-gaap Interest Expense
InterestExpense
1110000
us-gaap Interest Expense
InterestExpense
924000
us-gaap Interest Expense
InterestExpense
1112000
CY2016Q2 us-gaap Liabilities
Liabilities
19456000
CY2015Q4 us-gaap Liabilities
Liabilities
11604000
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2069000
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2880000
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
17323000
CY2015Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4821000
CY2016Q2 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
7111000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2095000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2055000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2949000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2595000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-4720000
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-587000
us-gaap Net Income Loss
NetIncomeLoss
-9012000
us-gaap Net Income Loss
NetIncomeLoss
-847000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
43000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
3330000
CY2015Q2 us-gaap Operating Expenses
OperatingExpenses
2981000
us-gaap Operating Expenses
OperatingExpenses
6515000
us-gaap Operating Expenses
OperatingExpenses
6155000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2107000
CY2015Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-2509000
us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
26000
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16000
CY2015Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
682000
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
371000
CY2015Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
387000
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
185000
us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
-16000
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2016Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2015Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2016Q2 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2015Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
330000
CY2015Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
575000
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
2000000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
2185000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
250000
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
407000
CY2015Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
412000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
20000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
75000
CY2016Q2 us-gaap Receivables Net Current
ReceivablesNetCurrent
909000
CY2015Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
590000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
90000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
10000
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-270795000
CY2015Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-261783000
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
174000
us-gaap Share Based Compensation
ShareBasedCompensation
349000
CY2015Q2 us-gaap Share Based Compensation
ShareBasedCompensation
209000
us-gaap Share Based Compensation
ShareBasedCompensation
1037000
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
303609
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1464154
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
-17387000
CY2015Q4 us-gaap Stockholders Equity
StockholdersEquity
-8724000
CY2016Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1919000
CY2015Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
509000
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55008
CY2015Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
35375
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55008
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30358

Files In Submission

Name View Source Status
0001437749-16-037506-index-headers.html Edgar Link pending
0001437749-16-037506-index.html Edgar Link pending
0001437749-16-037506.txt Edgar Link pending
0001437749-16-037506-xbrl.zip Edgar Link pending
cats-20160630.xml Edgar Link completed
cats-20160630.xsd Edgar Link pending
cats-20160630_cal.xml Edgar Link unprocessable
cats-20160630_def.xml Edgar Link unprocessable
cats-20160630_lab.xml Edgar Link unprocessable
cats-20160630_pre.xml Edgar Link unprocessable
cats20160531_10q.htm Edgar Link pending
ex10-1.htm Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
ex4-1.htm Edgar Link pending
ex4-10.htm Edgar Link pending
ex4-13.htm Edgar Link pending
ex4-14.htm Edgar Link pending
ex4-2.htm Edgar Link pending
ex4-3.htm Edgar Link pending
ex4-4.htm Edgar Link pending
ex4-5.htm Edgar Link pending
ex4-6.htm Edgar Link pending
ex4-7.htm Edgar Link pending
ex4-8.htm Edgar Link pending
ex4-9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending